secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0001104659-23-102132
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Armata promotes Rychlik to CFO; shareholders approve director elections and stock issuance
--------------------------------------------------------------------------------

- Richard Rychlik, Corporate Controller since Sept 5, promoted to principal financial officer, replacing Julianne Averill of Danforth Advisors who resigned as CFO.
- Shareholders elected seven directors to one-year terms: Deborah Birx, Jules Haimovitz, Odysseas Kostas, Robin Kramer, Joseph Patti, Todd Peterson, Sarah Schlesinger.
- Non-binding advisory vote on executive compensation approved: 29,620,537 for, 49,049 against, 14,773 abstentions.
- Shareholders ratified Ernst & Young as independent auditor for FY2023: 30,850,478 for, 37,396 against.
- Approved issuance of common stock upon conversion of loan from Innoviva Strategic Opportunities LLC under NYSE American rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465923102132/0001104659-23-102132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465923102132/tm2326466d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-102132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer